HCS Pharma

HCS Pharma

TBA
1,364 Views
HCS Pharma shares should be listed on the Frankfurt stock exchange in the next six months. The company is launching a pre-IPO on the European Digital Asset Exchange (EDSX) that will allow investors to buy shares with a 20% discount on the final listing price. HCS Pharma has already raised more than €2 million with private sales and has recently opened the public sales: https://www.edsx.ch/projects/hcs-pharma The goal is to raise €7 million to strengthen its position as a developer of regenerative medicine and cellular therapy.
1.9
TOTAL SCORE
3.1
ICO PROFILE

(weight: 45%)

1
TEAM PROOF

(weight: 20%)

Get widget
General
Website: Visit
Dates: TBA
Country: Switzerland
Token info
Ticker: HCS
Platform: Binance Chain
Financial
Raised $ 2,088,968
ICO Price: 1.00 EUR
Bonuses: 20%
HEIGHT - 0px
WIDTH - 0px
PUT THIS CODE TO YOUR WEBSITE
ICO List
Other Interesting ICOs
Upcoming
Shercoin
The SherCoin team has realized that the best way to create a good cryptocurrency that will achieve mass adoption is by creating a multi-functional token that has more than one utility. Most of the altcoins are Ethereum-based coins that only offer one application. SherCoin features five different related applications in one. The ecosystem has a theme: User provide valuable economic services for businesses such: as checking market place for counterfeits, reporting fake or suspicious products; filling out surveys and giving information, feedback, and data, so business can make informed decisions; giving the users an easy way to manage the cryptos the earned; and then giving them outlets to spend/exchange their tokens.
Upcoming
ReverseDAO
ReverseDAO is a solution to all of the problems above; it is a platform that connects the Metaverse with real-world assets. Fiat and economic units that are bound with world assets can now be represented, stored, and transferred onto the blockchain just as easily as cryptocurrencies.
Upcoming
Plentix
The advent of cryptocurrencies and the tokenized economy makes it possible to re-imagine the entire value chain of consumer, products, and producers from a referral perspective. We present Plentix, a tokenized platform that enables users to refer other users to a business entity and enables business entities to leverage existing APIs for industry specific referrals and allows for safe, secure, trustless value exchange to take place. Unlike other referral platforms, Plentix unleashes the potential of a new global ecosystem to monetize referrals for every stakeholder, from the producer to the consumer.
Upcoming
Sponsy
Sponsy is disrupting the sponsorship industry. It is a one-stop online solution for sponsors and sponsees to conduct sponsorship deals. By tokenizing sponsorship assets and decentralizing decision-making, we do not only reduce costs, but also provide sponsees with a wider choice of sponsorship opportunities and make sponsorships available to every business.
Upcoming
Little Phil
Powered by blockchain technology, the little Phil platform is an entirely new way of giving that fixes trust issues with charities using a public ledger, smart contracts and unique digital identities (UDID) to provide givers with the Proof of Need and Proof of Impact required to re-establish trust in giving to charity. Little Phil uses blockchain technology and user experience (UX) designed around a positive psychology framework to allow people to have the oversight, control and emotional connection of a philanthropist, without giving large amounts. People are able to give on their terms through their smartphone and track their giving all the way to the moment it’s received. This will create an engaging experience that makes them genuinely feel the positive impact they have had on their cause. In addition to this, charities will have solutions to their fundraising and exploitation concerns at a much lower cost than they currently incur.
Upcoming
Invictus Margin Lending
The Invictus Margin Lending Fund offers investors the ability to take advantage of the volatile nature of the cryptocurrency market without risking direct exposure. The fund aims to maximize interest income on USD and USD equivalents with zero anticipated drawdown risk by taking dollar-based positions on margin lending platforms.